SELLAS Life Sciences Group, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2016 | — | $-16.0M | $-17.7M |
| FY2017 | — | $-23.0M | $-23.8M |
| FY2018 | — | $-29.0M | $-27.7M |
| FY2019 | $0 | $-20.0M | $-19.3M |
| FY2020 | $1.9M | $-17.0M | $-16.8M |
| FY2021 | $7.6M | $-25.3M | $-20.7M |
| FY2022 | $1.0M | $-42.0M | $-41.3M |
| FY2023 | $0 | $-37.9M | $-37.3M |
| FY2024 | — | $-31.5M | $-30.9M |
| FY2025 | — | $-28.3M | $-26.9M |